Drug
Larsucosterol
Larsucosterol: highest development phase Phase 3, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| Larsucosterol NCT07428538 | Phase 3 | Hepatitis |
Latest
No recent events.
Follow Larsucosterol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.